An investigational T-cell therapy shows promise against six viral infections common after stem cell transplants
Bottom Line: Posoleucel, an investigational allogeneic off-the-shelf T-cell therapy that simultaneously targets six different viruses, demonstrated promising antiviral efficacy and ...